Roche's Avastin misses melanoma goal, after all - Reuters

ReutersRoche's Avastin misses melanoma goal, after allReutersOn the plus side, researchers also announced early-stage results from a Phase I trial with a different drug, called PLX4032, which produced impressive ...Hope over new skin cancer therapyBBC NewsRoche's Avastin Misses Goal In Skin Cancer StudyWall Street JournalRoche announces results from two early studies which show promise ...Insciences OrganisationTheMedGuru -Zee News -Wall Street Journalall 78 news articles »